L-Arginine prediabetes supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome health.
Go to PubMed and copy the title in the search field.
The effect of oral L-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremities.
Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials.
Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase.
Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.
Leptin-induced endothelial dysfunction in obesity.
Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury.
Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis.
A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.
The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.
Vascular insulin-like growth factor-I resistance and diet-induced obesity.